Medline, Inc. (MDLN)
43.44
+0.73
(+1.71%)
USD |
NASDAQ |
Jan 16, 12:42
Medline Market Cap: 34.19B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 212.70B |
| AIM ImmunoTech, Inc. | 3.971M |
| Perspective Therapeutics, Inc. | 175.81M |
| Protalix Biotherapeutics, Inc. | 165.27M |
| Armata Pharmaceuticals, Inc. | 234.15M |
Market Cap Related Metrics
| PE Ratio | 27.44 |
| PS Ratio | 1.267 |
| Price to Book Value | 2.038 |
| Price to Free Cash Flow | 34.43 |
| Price | 43.44 |
| Earnings Yield | 3.64% |
| Operating PE Ratio | 14.69 |
| Normalized PE Ratio | 27.76 |